News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Blaze Bioscience Inc. Ropes in $8.1 Million for Tumor Targeting "Paint"


7/3/2013 7:13:55 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Seattle-based startup Blaze Biosciences raises $8.1M in Series B funding for its tumor-targeting “paint” technology. healthcare funding

Blaze Biosciences is more than halfway to a targeted $15 million in a Series B round to fund its Tumor Paint, a surgical tool that visually distinguishes solid tumor cells from healthy cells.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES